Remove Clinical Supply Chain Remove Containment Remove Manufacturing
article thumbnail

Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective 

Pharmaceutical Technology

This is due to major differences throughout the clinical supply chain in both requirements and management practices. Below there are listed common differences across both the autologous and allogeneic CGT versus the traditional drug clinical supply chain: 1.

article thumbnail

AWS helps Pfizer accelerate drug development and clinical manufacturing

The Pharma Data

company (NASDAQ: AMZN), announced that it is working with Pfizer to create innovative, cloud-based solutions with the potential to improve how new medicines are developed, manufactured, and distributed for testing in clinical trials. (AWS), an Amazon.com, Inc.

article thumbnail

The Chemotherapy Drug Shortage: An Unprecedented Crisis

XTalks

Concerningly, the survey also revealed that only 40 percent of the surveyed NCCN cancer centers received any indication from manufacturers or suppliers about when carboplatin or cisplatin would be readily available again. Medicines for Europe said the supply issues were evidence of the damaging effects of European cost-containment measures.

Drugs 98